New chief scientific officer Tony Wood has said he is determined that GSK will take “smart risks” wherever opportunities present themselves – but has hinted that it will be “pragmatic” about expanding its presence in oncology.
Wood was speaking on his first call with analysts on the company’s 2 November third quarter business update, and set...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
